Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04978480 · ClinicalTrials.gov registry record
STROKE STAT (Stroke Severity-based Triage to Accelerate Treatment)
A clinical trial of Stroke, sponsored by University of Alabama at Birmingham.
- Active
- Registry status
- 4,893
- Enrollment target
- 1
- Study location
NCT04978480: Active study of Stroke, sponsored by University of Alabama at Birmingham.
NCT04978480 is a study of Stroke that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 4,893 participants, below the 12,006-participant average among 454 other Stroke trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04978480, a study of Stroke, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.
- ACTIVE NOT RECRUITING
- Registry status
- 4,893 participants
- Enrollment target
- 1
- Study location
Study Summary
Acute stroke systems of care should emulate trauma systems which deliver the full range of care to all injured patients by means of organized, coordinated efforts in defined geographic areas. Just as trauma systems have proven ability to save lives of the most severely injured patients, clinicians should have a stroke system able to provide care to patients with the most severe strokes. The most severe type of acute ischemic stroke is due to proximal large vessel occlusion (LVO). Mechanical thrombectomy (MT) offers an extraordinary potential to improve the outcome of patients with LVO. Unfortunately, in part because MT is available only at advanced stroke centers, only a minority of patients with LVO are treated with MT, and there are racial, socioeconomic, and rural disparities in access to MT. Based on the success of trauma systems and our prior collaboration, the Alabama Department of Public Health (ADPH) is planning a five-year statewide quality improvement initiative of trauma communications center (TCC) coordinated severity-based stroke triage (SBST) which aims to transform the fragmented acute stroke care system by coordinating prehospital and inter-facility emergency stroke care.
Primary Outcome
The investigators will compare the proportion of patients encountered by the Emergency Medical Service with suspected large vessel occlusion who are treated with mechanical thrombectomy before (adhering to standard triage to the nearest stroke center) and after implementation of Trauma Communications Center coordinated Severity-Based Stroke Triage
Conditions Studied
Interventions
- OTHER no intervention
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,893 participants |
| Start Date | 2022-04-29 |
| Est. Completion | 2026-12-31 |
What the registry record for NCT04978480 still lists
NCT04978480 is an observational study that tracks outcomes without assigning an intervention. Its 4,893 participants enrollment target places it among the larger protocols in the corpus, below the 12,006-participant average among 454 other Stroke trials with a reported enrollment target (59% lower).
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which no intervention is the first listed.
NCT04978480 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT04978480 about?
NCT04978480 is a clinical study titled "STROKE STAT (Stroke Severity-based Triage to Accelerate Treatment)". Acute stroke systems of care should emulate trauma systems which deliver the full range of care to all injured patients by means of organized, coordinated efforts in defined geographic areas. Just as trauma systems have proven ability to save lives of the most severely injured patients, clinicians s...
What is the current status of trial NCT04978480?
This trial is currently active not recruiting. The enrollment target is 4,893 participants. The study started on 2022-04-29. Estimated completion is 2026-12-31.
What conditions does trial NCT04978480 study?
This clinical trial studies the following conditions: Stroke.
What interventions are being tested in trial NCT04978480?
The interventions under investigation include: no intervention (OTHER).
Who is sponsoring clinical trial NCT04978480?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04978480 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04978480's enrollment target sits among peer trials
4,893 17th of 454 higher than 438 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
RECRUITING
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
RECRUITING
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05929976 · 4,900 participants
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
- NCT05252754 · 4,874 participants · Phase 3
Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
- NCT01719055 · 4,800 participants
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
- NCT05485675 · 4,800 participants · NA
Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI